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The purification and three-dimensional crystallization of membrane proteins are
commonly affected by a cumulation of pathologies that are less prevalent in
their soluble counterparts. This may include severe anisotropy, poor spot shape,
poor to moderate-resolution diffraction, crystal twinning, translational pseudo-
symmetry and poor uptake of heavy atoms for derivatization. Such challenges
must be circumvented by adaptations in the approach to crystallization and/or
phasing. Here, an example of a protein that exhibited all of the above-
mentioned complications is presented. Bestrophin-1 is a eukaryotic calcium-
activated chloride channel, the structure of which was recently determined in
complex with monoclonal antibody fragments using SAD phasing with tantalum
bromide clusters (Ta6Br12Br2). Some of the obstacles to obtaining improved
diffraction and phasing for this particular channel are discussed, as well as the
approach and adaptations that were key to determining the structure.
1. Introduction
Progress towards understanding the molecular mechanisms of
membrane proteins via the elucidation of atomic resolution
structures has lagged behind that of soluble proteins, largely
because of obstacles to high-level heterologous expression of
stable functional protein. Having overcome the initial hurdles
and having achieved crystallization of the protein of interest,
many membrane-protein crystallographers are then faced with
further challenges including anisotropic diffraction and diffi-
culty with heavy-atom incorporation. Several articles offer
overviews of approaches to membrane-protein handling and
crystallography and alternatives to traditional crystallization
methods (Lacape`re et al., 2007; Sonoda et al., 2011; Hammon
et al., 2009; Kang et al., 2013; Baker, 2010; Morth et al., 2006;
Caffrey & Cherezov, 2009), whereas in this work we will
discuss several aspects of one example: the calcium-activated
chloride channel.
Anion permeability through the membrane bilayer is
regulated in part by calcium-activated chloride channels
(CaCCs) including bestrophin-1 (Sun et al., 2002; Hartzell et
al., 2005, 2008). CaCCs are expressed in most eukaryotic cell
types and are required for functions ranging from epithelial
chloride secretion to neuronal and cardiac excitability to
olfactory transduction (Hartzell et al., 2005). Mutations in
bestrophins lead to retinopathies owing to a dysregulation of
chloride in the retinal pigment epithelium (Marquardt et al.,
1998; Petrukhin et al., 1998; Davidson et al., 2009). The channel
has a high affinity for calcium (Kd of 150 nM) and has been
proposed to have at least two domains of its primary sequence
devoted to calcium binding, including a conserved stretch of
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highly acidic amino acids (Qu et al., 2007; Xiao et al., 2008;
Kranjc et al., 2009).
Bestrophin bears no primary sequence similarities to any
other known family of anion channels, and the determination
of its atomic structure revealed a unique fold (DALI server;
Holm & Rosenstro¨m, 2010) featuring extensive domain-
swapping between subunits. The bestrophin channel is a
homopentamer comprising a central pore continuous with a
large cytosolic region (Fig. 1). The pore is accessible extra-
cellularly by a deep funnel-shaped entryway, narrowing to a
hydrophobic gate region near the midpoint of the membrane
and then widening to a positively charged intracellular cavity
with only a small aperture to the cytosol. Anion binding is
accomplished largely by interactions with helix dipoles, in
favour of direct interactions with polar residues, which echoes
a mode of stabilization seen in other anion channels and
transporters. Intracellular calcium-binding sites are situated
on the outside of the channel. Each subunit incorporates into
the calcium-binding site domains its neighbouring subunit,
termed the Ca2+-clasp, forming a belt-like structure of lateral
helices at the cytosol–membrane interface. The coordination
of the calcium ion is similar to that seen in EF-hand domains
or the Ca2+-bowl, but the nature of communication between
the Ca2+-clasp and the gate appears to be novel and requires
further study (Kane Dickson et al., 2014).
The initial purification and crystallization of bestrophin
provided a good indication that structural studies would be
achievable for this particular candidate. However, early
diffraction images demonstrated marked anisotropy and poor
spot shape, coupled with a very long
unit cell. This crystal form also exhib-
ited translational pseudo-symmetry.
Here, we describe the path from the
initial problematic diffraction to
phasing and structure solution.
2. Candidate selection and
purification
2.1. Candidate selection
Bestrophin exists in four isoforms in
humans and most higher eukaryotes,
denoted Best1, Best2, Best3 and Best4.
The conservation of the primary
sequence across all isoforms is very high
for residues 1–390 (55% identity), but
the remainder of the 600–700-amino-
acid protein is not very conserved. Early
screening involved cloning of both full-
length and truncated forms of each
isoform of the protein, where the trun-
cated candidates were designed to end
at the equivalent of human Best1
residue 398. This residue was selected
in part owing to a report that calcium
binding suffered if the protein was
shorter than residues 1–380 (human Best1 numbering; Xiao
et al., 2008), and the sequence conservation was increasingly
weak beyond residue 398. Protein that was truncated at this
point was shown to be active using an assay of purified,
reconstituted protein (Kane Dickson et al., 2014). Of the 30
eukaryotic candidate orthologues expressed as a GFP fusion
protein in HEK293 cells and screened by fluorescence size-
exclusion chromatography (FSEC; Kawate & Gouaux, 2006),
three were selected for further testing. Chicken Best1 residues
1–405 (GgBest1) was selected as one of the three top candi-
dates. The protein demonstrated a monodisperse elution peak,
as predicted by a sharp, symmetrical gel-filtration elution
profile, in a range of detergents. The candidate was then
moved from HEK293 cells to the larger-scale production
system Pichia pastoris.
2.2. Purification and initial crystallization
Purification was carried out using affinity purification via
the anti-tubulin YL1/2 antibody and gel filtration using a
Superdex 200 column. The purified channel demonstrated
good characteristics as assessed by gel filtration and was
functional as demonstrated by a flux assay (Kane Dickson
et al., 2014). A thermostability assay was carried out in the
presence of a range of specific inhibitors and ions using
analytical size-exclusion chromatography (SEC). To test
thermostability, the protein sample was prepared (at a
concentration of 1 mg ml1), combined with the compound of
interest and split into a control (20C) and eight samples in a
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Figure 1
Structure of chicken bestrophin-1. The overall structure is shown as viewed (a) from the plane of the
membrane and (b) from the outside of the cell. Each of the five subunits are identical and a single
subunit is coloured green for clarity. Approximate boundaries of the membrane are indicated.
Calcium ions are represented by cyan spheres. (c) Coordination in the Ca2+-clasp is shown including
a coordinated water molecule (red sphere).
PCR reaction strip and then incubated over a temperature
gradient between 42 and 67C for 20 min using a thermocycler.
Samples were then centrifuged at 20 800g for 30 min at 4C
and the supernatant was evaluated by the peak height of
tryptophan fluorescence in SEC. Analytical SEC (and fluor-
escence SEC) has become a powerful diagnostic tool in
assessing the stability of solubilized membrane proteins,
wherein the shape and height of the elution peak is diagnostic
of a monodisperse protein population. Gouaux and coworkers
have published a similar thermostability protocol using fluor-
escence SEC (FSEC; Hattori et al., 2012). Whereas using
purified and untagged protein for this purpose has the
advantage of reflecting the sample in the state that it will be
used for crystallography or functional assays, using a GFP-
tagged sample allows smaller sample sizes and could be
carried out using solubilized lysate samples. Using purified
protein for the purposes of this test, 20 mg of bestrophin was
used per compound, which could be reduced tenfold if using
FSEC. Alternatively, others have employed a fluorescent
labelling method as described in Alexandrov et al. (2008) to
assess thermostability. In this case, only Ca2+ was found to
improve the stability of the purified protein (Fig. 2). As a
result, 5 mM CaCl2 was added to the bestrophin samples used
for crystallization in a high-calcium condition. The sample
was routinely supplemented with 50 mM -aminobutyric acid
(GABA) before use for crystallization trials. GABA was
identified as an additive during crystal optimization via the
screening of inhibitors and permeable species, as it has been
reported to be a permeant species in glial cells (Lee et al.,
2010). GABA increased the number of well formed crystals in
all crystal forms but was not required for crystallization.
The protein was solubilized in n-dodecyl--d-malto-
pyranoside (DDM) and purified in DDM or another maltoside
for crystallization (Kane Dickson et al., 2014). Similar to the
GFP-labelled protein in FSEC screening, the protein purified
from Pichia also demonstrated stability over a range of
detergents and formed crystals in several detergents tested.
Initial diffraction patterns were collected from crystals formed
in DDM, n-decyl--d-maltopyranoside (DM) and n-octyl--d-
maltoside (OM). Diffraction ranged in quality but demon-
strated severe anisotropy (over 110 A˚2) that was not overcome
by changes in the detergent or other crystal-optimization
techniques. Crystals belonging to a rhombohedral space group
(R32) were optimized and diffracted to 3.6 A˚ resolution in the
best direction, but in addition to being severely anisotropic
were also found to exhibit pseudo-translational symmetry.
2.3. Co-purification with an antibody fragment
Following the observation of pathologies in the initial
bestrophin-only crystals, a parallel approach was taken to find
an alternate crystal form via the production of monoclonal
antibodies. Selection of the antibody for use in crystallization
involved eliminating those that bound to any unstructured
protein (assayed by positive reactions to denaturing ELISA)
and including a variety of populations that bound to struc-
tured regions. The Fab was prepared from purified IgG by
papain cleavage and ion-exchange chromatography and was
stored at20C. It was then quick-thawed and exchanged into
a complementary purification buffer (identical buffer and salt
composition but lacking detergent) immediately prior to
binding. Affinity-purified GgBest1 was combined with purified
Fab in a molar ratio of 1:1.2 and concentrated before appli-
cation onto a final gel-filtration column. The sample was
supplemented with 50 mM GABA and used directly for
crystallization trials. Four Fabs were used for crystal trials and
the final antibody selected generated two new crystal forms.
3. Crystallization and heavy-atom derivatization trials
Bestrophin readily formed crystals in the detergents DDM,
DM and CYMAL-6, among others. Optimized crystals which
contained the GgBest1–Fab complex were grown by vapour
diffusion either in CYMAL-6 or CYMAL-6 neopentyl glycol
(CYMAL-6-NG) against a well solution consisting of 0–
60 mM NaCl, 50 mM sodium acetate pH 4.0, 5% PEG 4000,
20% glycerol, generating crystals of the P21 crystal form, or in
DM against a well solution consisting of 120 mMNaCl, 50 mM
Tris pH 8.5, 8.5% PEG 4000, 20% glycerol, generating crystals
of the C2 form (Kane Dickson et al., 2014). Both forms were
grown by hanging-drop vapour diffusion using a 1:1 ratio of
protein solution to well solution either in 100–600 nl drops
(96-well format) or in 0.8–3.8 ml drops (24-well format). The
crystals varied in size but were easily large enough for
manipulation (over 50 mm). The C2 crystals required
progressive stepwise soaking for dehydration in 25% PEG 4K.
Both of these crystal forms suffered less anisotropic diffrac-
tion (of the order of 25 A˚2) and had improved spot shape
when compared with the bestrophin-only crystals. Transla-
tional pseudosymmetry was also absent, but the P21 form was
research papers
Acta Cryst. (2016). D72, 319–325 Kane Dickson  Phasing and structure of bestrophin-1 321
Figure 2
Effect of additives on the thermostability of GgBest1. Identical protein
samples were treated at a range of temperatures between 42 and 67C
using a thermocycler and then assessed by size-exclusion chromatography
monitored by tryptophan fluorescence. Traces are buffer control, blue;
DMSO, light blue; 5 mM CaCl2, yellow; 50 mM GABA, green; 100 mM
niflumic acid, red; 100 mM 5-nitro-2-(phenylpropylamino)benzoate
(NPPB), lilac; 100 mM dihydro-4,40-diisothiocyanostilbene-2,20-disulfonic
acid (DIDS), grey.
twinned when produced using protein purified in CYMAL-6
(twin fraction of up to 0.440; pseudomerohedral; operator
h, k, l).
Neither of the crystal forms resulting from Fab-complex
formation were successfully phased by molecular replacement
(MR) using an Fab fragment or assembly as a search model. A
post-mortem analysis of the failure of the MR trials revealed
that one of the major issues derived from the placement of
Fabs 2–5 in the helical density of the channel, which gave a
higher score than placement in the -sheet density of the Fabs.
One Fab was not sufficient for phasing on its own as it
comprised only 1/10 or 1/20 of the total mass of protein.
Crystals of both the P21 and C2 forms were subjected to
heavy-atom soaks in a wide range of derivatizing agents
(Table 1; see also Morth et al., 2006), some of which were more
likely to bind than others given the pH ranges that are optimal
for each compound (mostly pH 6–8) and the low pH of the P21
crystal form (pH 4). Many of the soaked crystals showed
diminished diffraction, but incorporation of the heavy atoms
was universally poor as indicated by their anomalous signal.
Co-crystallization was also attempted for many of the
compounds, especially multivalent cations that may associate
with a calcium-binding site, but the anomalous signal was not
improved. Note that although band-shift assays (changes in
electrophoretic mobility upon binding heavy atoms; see
Boggon & Shapiro, 2000; Bergfors, 2009) may help in selecting
candidates for binding of heavy atoms to soluble proteins, it is
not usually possible to gain useful information in this way for
many membrane proteins owing to their size and behaviour on
native protein gels.
4. Phasing with tantalum bromide
4.1. Derivatization with tantalum bromide
Data were collected from crystals produced using seleno-
methionine-substituted protein and from crystals produced in
sodium bromide (NaBr), but these data sets were not useful
for phasing. As the stoichiometry was unknown (Johnson et
al., 2013) but was expected to be between four and six subunits
per channel (with the mass of a channel–Fab complex there-
fore being of the order of 300–500 kDa), it was concluded that
perhaps the difficulty in phasing with bromide or selenium was
owing to the large number of relatively weak sites produced by
these derivatives, and phasing may be made possible by using
a large cluster compound that could bind at a single site per
subunit or even per channel. The only heavy-atom cluster
tested for this protein crystal was tantalum bromide
(Ta6Br12Br2), but several others are now commercially
available, including the magic triangle (Beck et al., 2009) and
tungsten-cluster salts (Rudenko et al., 2003), that may be
useful in similar circumstances by the same rationale.
Tantalum bromide (TaBr) has many useful properties as a
derivatizing agent for membrane proteins in addition to its
more historical use for large soluble assemblies (Kna¨blein et
al., 1997; Banumathi et al., 2003). Crucially, it is stable over
a wide pH range (4–8). Although some literature provided
with TaBr (Jena Bioscience; http://www.jenabioscience.com/
images/69db037406/PK-103.pdf) previously suggested the
preparation of a stabilization solution supplemented with the
cluster, the most practical way to deliver it to a crystal grown
by vapour diffusion is as a solid by way of introduction directly
into the drop (April 2015 revision). The drop can then be
observed over time and should turn green in colour as the
particulate is dissolved. This is beneficial since the detergent
concentration is not usually known with any accuracy, there-
fore preparing stabilizing solutions and cryoprotection solu-
tions for the addition of heavy-atom soaking solutions is time-
consuming and often leads to the destruction of several
samples. It is possible that delivery by this method also aids
in preservation of the crystal by a slow introduction of the
compound into the crystal. A second or third introduction of
solid can also be carried out. In the case of bestrophin, two
additions and an incubation of up to 7 d led to the highest
anomalous signal. When the tantalum bromide is incorporated
the crystals are also visibly green. It was possible to introduce
TaBr in this way for hanging drops as small as 150 nl + 150 nl.
It was essential that the remaining solid cluster compound was
stored under argon, and derivatization was most successful
when the TaBr sample used was less than two months old.
4.2. Phasing with tantalum bromide
The pitfalls of derivatization of GgBest1 by TaBr were that
it led to a decrease in resolution and changed the unit cell
sufficiently to make it non-isomorphous to native crystals.
SAD phasing was carried out using a tantalum bromide-
derived P21 crystal that diffracted to a resolution of 4.4 A˚.
A large variation in unit-cell parameters was also noted when
TaBr was used for phasing of the bacterial Complex I
(Efremov et al., 2010).
Even with a very high anomalous signal, phasing was not
successful using fully automated methods for SAD or MAD.
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Table 1
Compounds used for heavy-atom soaking and co-crystallization.
Compound Anomalous scatterer
KAuCN2 Au
BaCl2 Ba
NaBr Br
CdCl2 Cd
GdCl3 Gd
PCMB Hg
Thimerosal Hg
HgCl2 Hg
HoCl3 Ho
NaI I
Ir3Cl6 Ir
LaN3O9 La
OsCl3 Os
Pt3Cl6 Pt
K2PtI6 Pt
RbCl Rb
Sm(OAc)3 Sm
SrCl2 Sr
TlCl3 Tl
Na3[P(W3O10)4] W
YbCl3 Yb
The Patterson maps generated from the successfully phased
data set were complex, indicating either noise and/or a large
number of sites (Fig. 3). The SHELX interface via HKL2MAP
was used to identify candidate sites with strong cross-peaks
and these were manually evaluated until three sites generated
similar patterns in the synthetic Patterson maps to some of
those seen in the experimental Patterson maps. Using these
three sites, phasing was then possible via each automated
method attempted, namely SHARP/autoSHARP, Phaser EP
and SHELX. There were 25 cluster-binding sites found per
channel (i.e five sites per bestrophin monomer; none in the
Fabs), hence the complex maps observed. Occupancy was
especially high (>0.8) for the top ten sites, which corresponded
to two binding sites on the exterior of each bestrophin subunit
near the calcium-bound Ca2+-clasp.
5. Structure solution
Phasing using TaBr was carried out using a P21 crystal that
diffracted to 4.4 A˚ resolution with phasing information to only
6 A˚ resolution. As these data were non-isomorphous to other
data sets from crystals of the same form, structure building
was stepwise and involved both the C2 and P21 crystal forms.
At an early stage it was not known whether the two forms
would have the same structure owing to the vast difference in
pH (8.5 for the C2 crystal and 4.0 for the P21 crystal) and
the possibility of a pH-dependent second calcium-binding site.
Helical density and some side chains were clearly visible when
fivefold noncrystallographic symmetry (NCS) was applied
using operators generated by the positions of the TaBr clusters
in combination with phase extension. Fig. 4 clearly demon-
strates that it may not have been possible to build a useful
model at this resolution had NCS not been applicable. An
ideal helix model was built in the 4.4 A˚ resolution density, and
the directionality of the helices was correctly estimated based
on the appearance of the side chains. Fabs were manually
placed owing to difficulties in placing them by MR. The ideal
helix model in combination with the adjoining Fab was then
successfully used as a MR search model for the C2 crystal
form, where the best resolution available was 3.3 A˚. The C2
crystal form had two channels per asymmetric unit and
therefore had the benefit of tenfold NCS. Finally, the extended
helix and loop model was placed back into the P21 crystal form
by MR, using a native data set collected with diffraction to at
least 2.75 A˚ resolution. The register was then unambiguously
placed using ARP/wARP and confirmed by the anomalous
sulfur signals. Residues 2–367 were assigned with no breaks in
density, including the extended loop region of the C-terminus
(see the supplementary figure in Kane Dickson et al., 2014).
There was no discernible difference in the structure between
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Figure 3
Anomalous difference Patterson map calculated in the resolution range 6–20 A˚ for a data set containing 25 TaBr molecules per unit cell (a) and the
corresponding section of a synthetic map calculated from three unrefined sites (b). Maps are displayed using MapSlicer.
the two crystal forms (r.m.s.d. = 0.2 A˚) and no additional
calcium-binding sites were observed. It is notable that the final
improvement in diffraction of the P21 crystal form was
achieved by the use of a relatively new detergent class which
has been reported to aid in the stability of membrane proteins.
The detergent CYMAL-6-NG is comprised of two CYMAL-6
molecules bridged by a quaternary carbon that links their
hydrophilic maltoside head groups to their hydrophobic alkyl
chains (Fig. 5; see https://www.anatrace.com/Technical-
Documentation/Technical-Documents/ProdSpec_Det_NG.aspx).
Detergents of the ‘NG class’ have a much lower critical
micellar concentratrion than their nonlinked counterparts
and are thought to confer stability to solubilized membrane
proteins by packing more tightly in the micelle (Chae et al.,
2010). An additional new class has recently been described as
being stabilizing to membrane proteins and is characterized
by a glyco-diosgenin (DGN) head group (Chae et al., 2012). In
the case of the GgBest1–Fab complex, CYMAL-6-NG allowed
small improvements in the diffraction and reduction of the
twin fraction when compared with the crystals obtained using
CYMAL-6 (reduced from 0.225–0.440 to 0.017), which was
key to achieving the best resolved density.
6. Discussion and conclusions
The pursuit of the three-dimensional structures of membrane
proteins by X-ray crystallography, although not without its
challenges, has been rewarded in recent years and there are
now over 500 unique membrane-protein structures (SBKB
Membrane Proteins of Known Structure; White, 2015). In
many cases improvements have been brought about by
changes to the protein or its purification, mutation (Warne et
al., 2009), truncation (Hou et al., 2012), the use of thermo-
stable orthologues (Baradaran et al., 2013) or cross-linking
(Reyes et al., 2009). However, even when an exceptionally
stable sample is prepared, crystal packing between membrane-
spanning regions in detergent-solubilized proteins is not
generally observed. The presence of the detergent micelle
around the purified membrane protein reduces the surface
area available for forming crystal contacts relative to soluble
proteins. The resulting crystal contacts can lead to anisotropy
(and poor to moderate resolution) owing to the crystals
growing better in one or two dimensions than in the third.
When other issues such as poor uptake of heavy atoms or large
unit cells compound these challenges, it can be useful to try
phasing using large cluster compounds. These compounds
have exceptional phasing power, are useful at resolutions as
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Figure 4
Comparison of electron-density maps at 4.4 A˚ resolution following phase extension and density modification without (a) or with (b) the application of
fivefold NCS. The carbon backbone is shown in purple for reference only.
Figure 5
Three-dimensional structure of CYMAL-6 neopentyl glycol.
low as 8 A˚ and are likely to bind at fewer sites than smaller
heavy atoms owing to their large diameters.
In the case of bestrophin, several incremental improve-
ments were necessary to make the leap from initial diffraction
to the final structure. Firstly, the screening and purification
were optimized to find a stable and well expressed candidate.
Secondly, multiple crystal forms and ultimately the addition of
an antibody Fab improved the diffraction properties. Thirdly,
tantalum bromide was a useful and successful derivatizing
agent for phasing by SAD. Finally, changing the detergent in
the crystals led to an improved proportion of crystals with
good diffraction properties. In general, success in the pursuit
of membrane-protein structures starts with a stable protein
sample and benefits from the use of a multi-pronged strategy
at each stage.
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